Access to Vaccine Technologies in Developing Countries: Brazil and India
The authors of this study, published in the journal Vaccine, analyzed advantages and disadvantages of different ways vaccine manufacturers access new technologies. Among the methods considered were collaborations with academia and research institutions; technology transfer agreements with multinational corporations, public sector, or developing country organizations; and importation and finishing of bulk products.
Author(s): Milstien J, Gaule G, Kaddar M
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Milstien J, Gaule G, Kaddar M. Access to Vaccine Technologies in Developing Countries: Brazil and India. Vaccine. 2007;25(44):7610-7619.